Skip To Main Content
Kate Johnson on Muck Rack

Kate Johnson

  • Journalist and Editor, Medicine and Health, Freelance
  • Freelance Correspondent, Medscape
Montreal
As seen in: Medscape, LinkedIn, Center Republican, The New York Times, Daily Mail, The Telegraph, WebMD, ABC News (Australia), Memory Studies, PLOS, TechCrunch and
I'm a Montreal-based medical journalist writing for both physicians and the general public. My aim is to foster illuminating exchange between both audiences.

Get in touch with Kate

Contact Kate, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

¿Son eficaces las intervenciones digitales en salud mental?

|
By Kate Johnson
| Medscape Noticias Médicas Verified
Las intervenciones digitales universales en salud mental, destinadas a promover el bienestar y la resiliencia en infancias y jóvenes, se asocian con pequeñas mejoras en algunos resultados psicológicos, aunque la certeza general de la evidencia es baja, según una revisión sistemática y un metanálisis.[1] El estudio, publicado en npj Digital Medicine, abarcó 16 metanálisis de un total de 57 estudios, e incluyó a 43.973 participantes.
Open in Who Shared Issue with article?

Are Universal Digital Mental Health Interventions Effective?

|
By Kate Johnson
| Medscape Verified
Universal digital mental health interventions (DMHIs) aimed at promoting well-being and resilience in children and youth are associated with small improvements in some psychological outcomes, although the overall certainty of evidence is low, according to a systematic review and meta-analysis.
Open in Who Shared Issue with article?

Oral Nicotinamide: Cost-Effective for Reducing Keratinocyte Carcinoma Risk

|
By Kate Johnson
| Medscape Verified
Oral nicotinamide was cost-effective for reducing keratinocyte carcinoma (KC) risk in US veterans with a history of the disease, according to an economic analysis of Veterans Health Administration (VHA) data. The findings, published online June 10 in JAMA Dermatology, “support strong consideration of nicotinamide for KC prevention in high-risk populations like veterans, particularly given its safety and tolerability,” wrote senior author Rebecca I.
Open in Who Shared Issue with article?
See all 730 licensed articles (772 Total)